BrainsWay Ltd. (BWAY)
NGM – Real Time Price. Currency in USD
16.74
+0.01 (0.06%)
At close: May 12, 2026, 4:00 PM EDT
16.74
0.00 (0.00%)
After-hours: May 12, 2026, 5:42 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
16.74
+0.01 (0.06%)
At close: May 12, 2026, 4:00 PM EDT
16.74
0.00 (0.00%)
After-hours: May 12, 2026, 5:42 PM EDT
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
| Name | Position |
|---|---|
| Dr. Colleen Hanlon Ph.D. | Vice President of Medical Affairs |
| Dr. David Zacut M.D. | Co-Founder & Vice-Chairman |
| Dr. Yiftach Roth Ph.D. | Founder & Chief Scientific Officer |
| Mr. Dor Hagai | Vice President of Operations |
| Mr. Gilead Moiseyev Ph.D. | Chief Technology Officer |
| Mr. Hadar Levy | Chief Executive Officer |
| Mr. Ido Marom | Chief Financial Officer |
| Mr. Menachem C. Klein Esq. | VP, General Counsel & Corporate Secretary |
| Mr. Michael Cohen | Vice President of US Sales |
| Prof. Abraham Zangen Ph.D. | Co-Founder, Member of Scientific Advisory Board & Director |
| Date | Type | Document |
|---|---|---|
| 2026-04-20 | S-8 POS | fs8pos_041626.htm |
| 2026-04-20 | S-8 | fs8_041626.htm |
| 2026-04-15 | 6-K | f6k_041426.htm |
| 2026-03-26 | 6-K | f6k_032526.htm |
| 2026-03-19 | 6-K | f6k_031926.htm |
| 2026-03-17 | 6-K | f6k_031726.htm |
| 2026-03-11 | 6-K | f6k_031126.htm |
| 2026-03-05 | 6-K | f6k_030526.htm |
| 2026-02-19 | 6-K | f6k_021726.htm |
| 2026-02-18 | 6-K | f6k_021726.htm |